PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting novel delivery methods to enhance patient outcomes. The Company’s lead product is KETARX™ (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is commercializing PharmaPATCH (microneedle patch) and PharmaDOSE (enteric coated) with its partners to deliver psychedelics, stem cells, gene therapy, and drugs for medical countermeasures (i.e. biothreats, infectious diseases).
Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record of success in drug development, business development and capital markets.
Connect With Us
PharmaTher Holdings Ltd. 82 Richmond Street East Toronto, Ontario Canada M5C 1P1